Daniel Lochner

No open positions remaining

Net worth: 2 M $ as of 30/05/2026

44 year

79 connections

Health Technology

Consumer Services

Commercial Services

Profile

Daniel Lochner is currently Chief Financial Officer at Tectonic Therapeutic, Inc. and Chief Financial Officer at Tectonic Operating Co., Inc., both starting in 2024.
Former positions include Chief Financial Officer at AVROBIO, Inc. in 2024, Chief Financial & Business Officer-Eye Care at Viatris, Inc. from 2023 to 2024, Chief Financial & Business Officer at Oyster Point Pharma, Inc. from 2022 to 2023, and Portfolio Manager at Goldman Sachs Asset Management LP from 2005 to 2019.
Education includes an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Richmond.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
0.31%	10/06/2026	58,544 ( 0.31% )	2 M $	30/05/2026

Daniel Lochner active positions

Companies	Position	Start
Tectonic Therapeutic, Inc. Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies	Director of Finance/CFO	31/05/2024

All active positions of Daniel Lochner

Former positions of Daniel Lochner

Companies	Position	End
VIATRIS INC.	Corporate Officer/Principal	31/03/2024
OYSR POIN	Director of Finance/CFO	31/12/2022
Goldman Sachs Asset Management LP Goldman Sachs Asset Management LP Investment ManagersFinance GSMALP offers a wide array of investment strategies that span asset classes, industries, and geographies. The firm's products and services across a full range of asset classes including fixed income, money markets, public and private equity, commodities, hedge funds, and real estate. Clients access these solutions through GSAM's proprietary strategies, strategic partnerships, and open architecture programs.	Portfolio Manager-Equities	30/06/2019
TECTONIC THERAPEUTIC, INC.	Director of Finance/CFO	-

See the detail of Daniel Lochner's experience

Training of Daniel Lochner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Lochner's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Goldman Sachs Asset Management LP Goldman Sachs Asset Management LP Investment ManagersFinance GSMALP offers a wide array of investment strategies that span asset classes, industries, and geographies. The firm's products and services across a full range of asset classes including fixed income, money markets, public and private equity, commodities, hedge funds, and real estate. Clients access these solutions through GSAM's proprietary strategies, strategic partnerships, and open architecture programs.	Finance
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Richmond University of Richmond Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AVROBIO, Inc. AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose	Health Technology
Oyster Point Pharma, Inc. Oyster Point Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops and commercializes pharmaceutical therapies to treat ocular surface diseases	Commercial Services
Viatris, Inc. Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products	Health Technology
Tectonic Therapeutic, Inc. Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies	Commercial Services